NIMH NCDDG U01: Cooperative Drug & Device Discovery for Mental Disorders (Clinical Trial Optional)
This NIMH U01 opportunity supports multidisciplinary academic–industry cooperative groups (NCDDGs) to discover and advance novel drugs, biologics, and neuromodulation devices for mental disorders. Funding can support work from target/ligand discovery through preclinical development and first‑in‑human or Phase I studies, emphasizing safety, target engagement, PK/PD, and biomarker development; p…
The intent of this NOFO is to encourage applications from academic, biotechnology, biomedical device industry, or pharmaceutical industry investigators interested in participating with the National Institute of Mental Health (NIMH) in a National Cooperative Drug/Device Discovery/Development Grou…
Funding Source
Eligibility
- Foreign/Non-domestic eligibility: Non-domestic (non-U.S.) Entities (Foreign Organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are NOT eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers